PMID- 13678560 OWN - NLM STAT- MEDLINE DCOM- 20040106 LR - 20191107 IS - 1523-3812 (Print) IS - 1523-3812 (Linking) VI - 5 IP - 5 DP - 2003 Oct TI - Cognitive and neuropsychiatric aspects of subclinical hypothyroidism: significance in the elderly. PG - 384-90 AB - The effects of overt hypothyroidism (HO) on cognition and mood are well established, and HO is considered a common cause of reversible dementia. There is now increasing evidence to suggest that subclinical hypothyroidism (ie, elevated thyroid stimulating hormone in the presence of normal thyroxine concentrations) may be a predisposing factor for depression, cognitive impairment, and dementia. Subclinical hypothyroidism is more common than HO and is most prevalent in the elderly, particularly in women. Older adults may be more vulnerable to the effects of subclinical hypothyroidism, given age-related changes to the hypothalamic-pituitary-thyroid axis, and there is an association between thyroid status and cognitive decline and dementia in the elderly. The purpose of this review is to summarize existing data on the cognitive and neuropsychiatric consequences of subclinical hypothyroidism, benefits of treatment, and recommendations for screening and monitoring in older adults. FAU - Davis, Jennifer Duncan AU - Davis JD AD - Brown Medical School, Rhode Island Hospital Physicians Office Building, Suite 430, 110 Lockwood Street, Providence, RI 02903, USA. jdavis3@lifespan.org FAU - Stern, Robert A AU - Stern RA FAU - Flashman, Laura A AU - Flashman LA LA - eng PT - Journal Article PT - Review PL - United States TA - Curr Psychiatry Rep JT - Current psychiatry reports JID - 100888960 RN - Q51BO43MG4 (Thyroxine) SB - IM MH - Aged MH - Clinical Trials as Topic MH - Cognition Disorders/etiology/*prevention & control/psychology MH - Dementia/etiology/*prevention & control/psychology MH - Depressive Disorder/etiology/*prevention & control/psychology MH - Humans MH - Hypothalamo-Hypophyseal System/physiopathology MH - Hypothyroidism/complications/drug therapy/*psychology MH - Pituitary-Adrenal System/physiopathology MH - Risk Factors MH - Thyroid Function Tests/methods MH - Thyroxine/therapeutic use RF - 48 EDAT- 2003/09/19 05:00 MHDA- 2004/01/07 05:00 CRDT- 2003/09/19 05:00 PHST- 2003/09/19 05:00 [pubmed] PHST- 2004/01/07 05:00 [medline] PHST- 2003/09/19 05:00 [entrez] AID - 10.1007/s11920-003-0073-6 [doi] PST - ppublish SO - Curr Psychiatry Rep. 2003 Oct;5(5):384-90. doi: 10.1007/s11920-003-0073-6.